A Phase 1, Open-label Study to Compare the Pharmacokinetics and Pharmacodynamics of Warfarin and Esmolol in the Absence and Presence of MEDI0382 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2018
At a glance
- Drugs MEDI 0382 (Primary) ; Esmolol; Warfarin
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors MedImmune
- 24 Apr 2018 Status changed from active, no longer recruiting to completed.
- 28 Mar 2018 Planned End Date changed from 10 May 2018 to 9 Apr 2018.
- 28 Mar 2018 Planned primary completion date changed from 10 May 2018 to 9 Apr 2018.